Microphysiological Systems Integrating Bioprinting, Organoids, Organ-on-a-Chip, and AI: Next Generation Platforms for Pharmaceutical Development.
Microphysiological systems (MPS) have emerged as transformative in vitro platforms to address the long-standing bottlenecks of conventional preclinical models, including poor physiological relevance inherent to 2D cultures, as well as species incompatibility and ethical constraints associated with animal models, thereb...